Walleye Capital
CELU icon

Walleye Capital’s Celularity CELU Stock Holding History

Walleye Capital’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,800
Closed -$181K – 1360
2021
Q1 		$181K Sell
1,800
-4,131
-70% -$423K 0.01% 943
2020
Q4 		$652K Sell
5,931
-5,015
-46% -$533K 0.04% 390
2020
Q3 		$1.15M Sell
10,946
-1,727
-14% -$179K 0.13% 216
2020
Q2 		$1.29M Buy
+12,673
New +$1.26M 0.29% 104

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PT
Palantir Technologies Aventura, Florida $9.72M AUM 6.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LDFO
Louis-Dreyfus Family Office Wilton, Connecticut $64.7M AUM 21.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Walleye Capital's CELU Position: Q2 2021 in Review

Walleye Capital sold out of Celularity (CELU) in Q2 2021, closing a stake of 1,800 shares — an estimated $181K sold.

Walleye Capital first reported a position in CELU in Q2 2020 and held it in 4 quarters. The position peaked at $1.29M in Q2 2020. 33 funds tracked by Wall St. Rank hold CELU as of Q2 2021.

  • Walleye Capital reported no remaining Celularity position as of Q2 2021 after selling out during the quarter.
  • Walleye Capital sold 1,800 Celularity shares in Q2 2021, an estimated $181K.
  • Walleye Capital first reported a position in Celularity in Q2 2020 and held it in 4 quarters.
  • Walleye Capital's Celularity position peaked at $1.29M in Q2 2020.
  • 33 funds tracked by Wall St. Rank held Celularity as of Q2 2021.

Based on Walleye Capital's 13F filing for Q2 2021, filed 16 Aug 2021.